Global Blood Therapeutics (GBT) Reports In-Line Q3 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 2/9/2023
- Wall St falls after recent strong gains, Alphabet shares sink
- Disney Q1 results beat estimates as theme parks business shines
- Affirm Holdings shares sink after earnings miss; cutting 19% of jobs
- CVS Health (CVS) confirms deal to buy Oak Street Health (OSH) for $10.6 billion
- Mattel Q4 results fall short of estimates as challenging macroenvironment weighs
- AVROBIO (AVRO) exploring potential sale after Novartis interest - source
- Salesforce (CRM) ticks up on tweet from Marc Benioff about EinsteinGPT
- Ford Motor (F) Declares $0.65 Special Dividend; 4.5% Yield
- Wall St falls after recent strong gains, Alphabet shares sink
- BlackRock (BLK) Announces Resignation of Beth Ford from Board
- After-hours movers: Disney gains on results and job cuts, Affirm plunges
- Uber, Under Armour, Coty, Microsoft rise premarket; Chipotle falls
- After-hours movers: Chipotle falls on miss, Fortinet gains on beat
- Midday movers: Bed Bath&Beyond, Chegg, Zoom Video and more
- Bed Bath&Beyond, Chegg fall premarket; Boeing, Hertz, BP rise
Form 8-K Global Blood Therapeutic For: Nov 09
November 9, 2016 4:06 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
Form 8-K
_____________________
CURRENT REPORT
Pursuant to Section 13 or... More
